Fulcrum Therapeutics Company
Fulcrum Therapeutics is a biotechnology company developing new medicines to deliver a new future to patients.
Technology:
Cancer
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2016
Employees Number:
51-100
Funding Status:
IPO
Total Funding:
333499987
Estimated Revenue:
$1B to $10B
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership